Division
The majority voted against an [amendment](https://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;query=Id:legislation/billhome/display.w3p;query=Id%3A%22legislation%2Famend%2Fr7345_amend_96f6853d-1629-4dea-a198-f2680a3703ed%22;rec=0) to the usual second reading motion, which is "that the bill be read a second time" (parliamentary jargon for agreeing with the main idea of the bill), which means it failed. ### Amendment text > *At the end of the motion, add “, but the Senate:* > > *(a) notes with concern the Government’s continuing delays in implementing the recommendations of the Health Technology Assessment review; and* > > *(b) condemns the Prime Minister’s failure to secure a meeting with the President of the United States to advance Australia’s interests in relation to possible pharmaceutical tariffs and other issues”.*
Senate, 2025-09-01. negative: ayes 22, noes 34.
Question
The majority voted against an [amendment](https://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;query=Id:legislation/billhome/display.w3p;query=Id%3A%22legislation%2Famend%2Fr7345_amend_96f6853d-1629-4dea-a198-f2680a3703ed%22;rec=0) to the usual second reading motion, which is "that the bill be read a second time" (parliamentary jargon for agreeing with the main idea of the bill), which means it failed. ### Amendment text > *At the end of the motion, add “, but the Senate:* > > *(a) notes with concern the Government’s continuing delays in implementing the recommendations of the Health Technology Assessment review; and* > > *(b) condemns the Prime Minister’s failure to secure a meeting with the President of the United States to advance Australia’s interests in relation to possible pharmaceutical tariffs and other issues”.*
How each member voted
Per-member votes are not present in this static export. Consult the original division record.
Related bills
Only formal divisions leave a per-member record. A procedural vote is not necessarily a vote for or against a bill.